Skip to main content

Table 4 Multivariate analysis of the effect of simvastatin in improving the survival

From: Survival benefits of adding simvastatin to standard therapy for secondary prevention of bleeding esophageal varices in patients with hepatitis C-related liver cirrhosis

 

Multivariate

OR (95% CI)

p-value

Encephalopathy

0.725 (0.352–1.652)

0.998

Survival

0.136 (0.020–0.916)

0.040*

Myalgia

5.812 (0.658–51.361)

0.113

Child score

4.419 (0.874–22.341)

0.072